Evaluation comparison and standardization of arthritis drugs

Evaluation comparison and standardization of arthritis drugs


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 3,651

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Arthritis is the inflammation of a joint, which can include infiltration of inflammatory cells, synovial hyperplasia, bone erosion and new bone formation, narrowing of the joint space. Arthritis was induced in knee joint cavity of the right hind leg by intra-articular injection of 0.1ml of 1% carrageenan in all groups except control group. Animals are divided into five different groups such as Normal control, arthritis control, Standard A (MOOV) treated group, Standard B (RUMALAYA) treated group and test drug treated group. Catalase activity, Alkaline Phosphatase, MDA and Uric acid were significantly (p < 0.001) altered or comes close to the control group in test drug treated group. Paw volume, Knee diameter and body weight were altered in test drug treated group as compare to reference standard A and B. So we concluded that VPR-011 show significant anti-arthritic activity and better efficacy than other reference standard drugs (MOOV) and (RUMALAYA).

Product Specifications
SKU :COC31620
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-31
0 Review(s)